ITMCTR2000003430
Not yet recruiting
Phase 1
A prospective randomized controlled clinical trial for QSHY granule in the treatment of hyperlipidemia of phlegm and blood stasis type
Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. For patients who meet the diagnostic criteria of Chinese and Western medicine for hyperlipidemia, the guidelines for the prevention and treatment of Chinese adult dyslipidemia in 2016 were revised by referring to the guidelines for the prevention and treatment of Chinese adult dyslipidemia. TCM diagnosis, syndrome differentiation criteria and their basis refer to the TCM diagnosis and treatment criteria for dyslipidemia of the heart disease branch of the Chinese society of TCM.
- •2\. Patients older than 18 years old;
- •3\. In the absence of ASCVD, 3\.4mmol/l (130mg / dl) was less than 4\.9mmol/l (190mg / dl); in the absence of ASCVD, 2\.6mmol/l (100mg / dl) was less than 4\.9mmol/l (190mg / dl);
- •4\. Patients with fasting TG \< 5\.7 mmol/L (500mg/dL);
- •5\. BMI \< 35 kg/m2;
- •6\. Willing and able to follow the scheduled visit plan, diet and exercise instructions, laboratory tests and other procedures.
- •7\. Patients who signed informed consent.
Exclusion Criteria
- •1\. The patients who used other lipid\-lowering drugs in the first 4 weeks were screened;
- •2\. Patients with uncontrolled endocrine or metabolic diseases that may interfere with blood lipid levels;
- •3\. Patients taking oral corticosteroids;
- •4\. Screening of patients with a history of alcohol or narcotic drug abuse in the previous year;
- •5\. Patients with high or very high risk of ASCVD;
- •6\. Patients with congestive heart failure, unstable angina, myocardial infarction, stroke, coronary artery bypass surgery or angioplasty, or unstable or serious peripheral artery disease in the first 6 months were screened;
- •7\. Patients who have undergone gastrointestinal surgery in the past year or who have taken weight\-loss drugs in the past 3 months have lost more than 10% of their body weight;
- •8\. Pregnant women, lactating women and patients with cardiovascular, lung, kidney, hematopoietic system and other major diseases such as malignant tumors.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Communication management: a trial comparing two strategies for information communication to patientsISRCTN01508870Donostia University Hospital (Hospital Universitario Donostia) (Spain)30
Not yet recruiting
Phase 2
To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/08/027346Shri Dhanwantry ayurevdic college and hospital
Recruiting
Not Applicable
A prospective randomized controlled clinical trial of Pingmu Decoction combined with acupuncture in the treatment of non-active thyroid-related ophthalmopathyThyroid associated ophthalmopathyITMCTR2100004405onghua Hospital, Shanghai University of Traditional Chinese Medicine
Completed
Not Applicable
A prospective randomised controlled clinical trial to evaluate methods of dressing removal, in respect of time and comfort, for boys undergoing hypospadias repairrological and Genital Diseases: Hypospadias repairUrological and Genital DiseasesHypospadias repairISRCTN15032217Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)60
Completed
Not Applicable
The efficacy and safety of temperature-controlled radiofrequency for the treatment of vaginal laxity in Chinese postpartum womeTreatment of vaginal laxity in Chinese postpartum womenUrological and Genital DiseasesISRCTN35181035Tsinghua University150